PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsSelenium
Selenium
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
305 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
MalnutritionD044342EFO_0008572E40-E46—134715
InfertilityD007246HP_0000789——2—1912
NeoplasmsD009369—C802—23411
Autoimmune thyroiditisD013967EFO_0006812E06.3—2—158
Male infertilityD007248EFO_0004248N46—1—168
Thyroid diseasesD013959HP_0000820E00-E07—33138
ThyroiditisD013966—E06—2—147
Hashimoto diseaseD050031EFO_0003779E06.3—1—146
SepsisD018805HP_0100806A41.9—21126
RecurrenceD012008——1122—5
Show 44 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Prostatic neoplasmsD011471—C61374—215
InflammationD007249MP_0001845——12—69
Covid-19D000086382———31—58
AnemiaD000740HP_0001903D64.9——2—68
Healthy volunteers/patients————11—57
CarcinomaD002277—C80.0331——5
Colorectal neoplasmsD015179——112—15
Diabetes mellitusD003920HP_0000819E08-E131—1—35
PregnancyD011247EFO_0002950Z33.11—1—35
Graves ophthalmopathyD049970EFO_1001466——23—25
Show 63 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
SyndromeD013577———1——67
Breast neoplasmsD001943EFO_0003869C50—1——45
FibrosisD005355———1——34
Renal cell carcinomaD002292EFO_0000376—21———2
ToxemiaD014115———1——12
Septic shockD012772—A48.3—2———2
ShockD012769—R57.1—2———2
ThyrotoxicosisD013971—E05.9—1——12
Squamous cell carcinoma of head and neckD000077195———1——12
AdenocarcinomaD000230———1———1
Show 26 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Type 2 diabetes mellitusD003924EFO_0001360E111———23
IschemiaD007511EFO_0000556—1———12
GlioblastomaD005909EFO_0000515—1————1
DiseaseD004194EFO_0000408R691————1
Congenital abnormalitiesD000013EFO_0003915Q89.91————1
LymphangiomaD008202—D18.11————1
Lymphatic abnormalitiesD044148——1————1
AtrophyD001284——1————1
GastritisD005756EFO_0000217K29.71————1
Atrophic gastritisD005757EFO_1000826K29.41————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Iron deficienciesD000090463——————66
Iron-deficiency anemiaD018798HP_0001891D50————44
Polycystic ovary syndromeD011085EFO_0000660E28.2————33
ObesityD009765EFO_0001073E66.9————33
MicronutrientsD018977——————33
DiarrheaD003967HP_0002014R19.7————33
Metabolic syndromeD024821EFO_0000195E88.810————33
OverweightD050177—E66.3————33
HyperthyroidismD006980—E05.9————33
HypertensionD006973EFO_0000537I10————33
Show 118 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use